Inovio Pharmaceuticals, Inc. (INO)
1.11
+0.02
(+1.83%)
USD |
NASDAQ |
Jun 09, 14:03
Inovio Pharmaceuticals SG&A Expense (Quarterly) : 7.880M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 43.52M |
| ADMA Biologics, Inc. | 27.80M |
| Agenus, Inc. | 6.86M |
| Vertex Pharmaceuticals, Inc. | 493.70M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |